Finch Therapeutics - Ownership and Business Overview

Life ScienceCompany

Finch Therapeutics Ownership

Who owns Finch Therapeutics?

.

Finch Therapeutics Business Overview

Where is Finch Therapeutics headquartered?

Finch Therapeutics is headquartered in Boston, Massachusetts.

What is Finch Therapeutics’ revenue?

Finch Therapeutics disclosed revenue of 19M USD for 2021 and 8M USD for 2020.

What sector is Finch Therapeutics in?

Finch Therapeutics is a life science company.

When was Finch Therapeutics founded?

Finch Therapeutics was founded in 2014.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Finch Therapeutics

Finch Therapeutics Group, Inc.

75 State Street, Suite 100,
Boston, Massachusetts 02109
United States,
(617) 229-06499
www.finchtherapeutics.com

Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted microbiome therapeutics. Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. Finch plans to initiate a Phase 3 trial, referred to as PRISM4, as its second pivotal trial of CP101 for recurrent CDI. Finch Therapeutics was founded in 2014 and is headquartered in Boston, Massachusetts.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.